Drugs that contain Isavuconazonium Sulfate

1. Drug name - CRESEMBA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6812238 ASTELLAS N-substituted carbamoyloxyalkyl-azolium derivatives
Oct, 2025

(3 years from now)

CN1185230C ASTELLAS N-Substituted Carbamoyl Oxy Alkyl-Pyrrole Derivatives
Oct, 2020

(1 year, 11 months ago)

CN1387529A ASTELLAS N-Substituted Carbamoyl Oxy Alkyl-Pyrrole Derivatives
Oct, 2020

(1 year, 11 months ago)

EP1280795A2 ASTELLAS N-Substituted Carbamoyloxyalkyl-Azolium Derivatives
Oct, 2020

(1 year, 11 months ago)

EP1280795B1 ASTELLAS N-Substituted Carbamoyloxyalkyl-Azolium Derivatives
Oct, 2020

(1 year, 11 months ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10206879 ASTELLAS Active ingredient containing stabilised solid forms and method for the production thereof Sep, 2027

(4 years from now)

US10603280 ASTELLAS Active ingredient containing stabilised solid medicinal forms and methods for the production thereof Sep, 2027

(4 years from now)

Treatment: NA

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
372MG POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.